Next, we investigated whether leukaemic cells from both studied groups of CLL patients, in particular from the low CTLA-4 expressors, are able to change CTLA-4 expression in response to ex vivo stimulation with DSP30 and rIL-2. Here, CTLA4 is linked to B-cell chronic lymphocytic leukemia.